This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.
This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.
This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from...
This report provides World Health Organization (WHO) member states with guidance on preventing TB transmission in healthcare facilities, congregate settings, and households. It focuses on what to do and how to prioritize TB infection control at national levels and includes recommendations for...
By the end of this webinar, participants will be able to: explain the impact that population mobility bears on public health within the context of globalization, outline strategies and approaches for addressing challenges of TB management and care among migrants, and develop strategies and best...
In this webinar, participants hear from public health professionals about the impact of COVID-19 on TB program services. Topics addressed include programmatic adjustments during COVID-19, changes in clinical care and community work, and TB control activities during COVID-19. The webinar also...
